Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer

BACKGROUND: We performed a retrospective analysis to determine the incidence of neurotrophic tropomyosin-receptor kinase (NTRK) fusion in non-small cell lung cancer (NSCLC). METHODS: Archival NSCLC tissues between 2018–2020 were screened by immunohistochemistry (IHC) with IHC-positive cases undergoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Poh, Ashleigh, Sammour, Abdelaziz, Mathai, Jared, Peverall, Joanne, Van Vliet, Chris, Asadi, Khashayar, Parakh, Sagun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407491/
https://www.ncbi.nlm.nih.gov/pubmed/37559603
http://dx.doi.org/10.21037/jtd-23-113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407491/
https://www.ncbi.nlm.nih.gov/pubmed/37559603
http://dx.doi.org/10.21037/jtd-23-113

Ejemplares similares